Meridian Bioscience Comments on DOJ Announcement Regarding Former Executives of Magellan Diagnostics
CINCINNATI, April 5, 2023 /PRNewswire/ — Meridian Bioscience, Inc. learned today that certain former employees of Magellan, a subsidiary of Meridian acquired in March 2016, were charged by the United States Attorney for the District of Massachusetts for alleged violations of certain federal laws. Meridian and its subsidiaries are not defendants in the action. As previously disclosed, Meridian and Magellan have cooperated […]